Phosphodiesterase 4 Inhibitor Use in Pediatric Patients With Atopic Dermatitis: A Meta-Analysis of Randomized Controlled Trials

PDE4 inhibitors might be an effective and safe treatment option for pediatric patients with AD.

Authors

Institutions

Publication Details

Journal
Advances in Skin & Wound Care
Published
2026-03-04
DOI
https://doi.org/10.1097/asw.0000000000000423
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phosphodiesterase 4 Inhibitor Use in Pediatric Patients With Atopic Dermatitis: A Meta-Analysis of Randomized Controlled Trials

Shao‐Huan Lan, Li-Chin Lu, Gui-Lin Ran, Jun-He Yang et al.
Advances in Skin & Wound Care
Dermatology and Skin Diseases
article

Phosphodiesterase 4 Inhibitor Use in Pediatric Patients With Atopic Dermatitis: A Meta-Analysis of Randomized Controlled Trials

Shao‐Huan Lan, Li-Chin Lu, Gui-Lin Ran, Jun-He Yang, Hui-Bin Wang, Chia-Pang Chan, Hua-Mei Zhuang
article en

Abstract

PDE4 inhibitors might be an effective and safe treatment option for pediatric patients with AD.

Advances in Skin & Wound CareVol. 39(3)
Fujian Medical University (CN), Open University of Kaohsiung (TW), The People's Hospital Tongling (CN), Putian University (CN), Cheng Shiu University (TW)
Openalex Percentile: Top 17%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.